Sen. Josh Hawley from Missouri has serious concerns about Dr. Mehmet Oz, the nominee for the Centers for Medicare & Medicaid Services (CMS) under President Trump. He’s worried about Oz’s past views on transgender treatments for minors and abortion. Despite sending Dr. Oz several questions about these issues, Hawley says he hasn’t received any responses. "Which I think is strange," he remarked.
Hawley hopes that Oz’s views may have shifted to align more closely with Trump’s stance, especially as the President has been vocal about these issues. A spokesperson for the White House stated that everyone in Trump’s administration is on the same page, aiming to restore sensible policies to healthcare.
The spotlight on Dr. Oz’s past stems from his television show, where he has discussed transgender issues. In a notable 2010 episode titled "Transgender Kids: Too Young to Decide?", he featured children discussing their gender identities, highlighting their experiences with hormone treatments and surgeries. This episode drew praise from many LGBTQ activists for bringing visibility to transgender issues.
Historically, debates surrounding transgender rights and treatments for minors have polarized communities. Recently, numerous states have moved toward legislating restrictions on such medical options, igniting conversations about healthcare, parental rights, and the role of government in personal decisions. A Gallup poll from 2022 showed that public opinion is split on the issue, with about 49% of Americans believing transgender youth should have the right to access hormone therapy.
Dr. Oz has also faced criticism for his abortion views. During his Senate campaign in Pennsylvania in 2022, he expressed that he doesn’t believe in federal government oversight of abortion decisions, favoring state discretion. This stance came under fire during a debate with his opponent, John Fetterman.
Oz’s past comments on the subject show a complex relationship with abortion. In a 2019 radio interview, he described the state laws restricting abortion as concerning. He acknowledged it as a challenging topic for many, yet maintained he personally wouldn’t wish to impose his beliefs on others.
When asked if he would support confirming Oz without getting answers to his questions, Hawley remained noncommittal. “I just have to believe that he will respond here,” he said, leaving the door open for future conversations.
As discussions on these topics intensify, public opinion is likely to play a crucial role in shaping the landscape. Oz’s confirmation will not only affect CMS but could also redefine how healthcare policies address issues of gender identity and reproductive rights in the U.S.
For more context on these ongoing discussions, you can check out Gallup’s polling data on abortion and gender identity.